Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMQT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $123,589
Award facts
- Contract value 100% obligated
- $123,588.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $123,588.96 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on January 12, 2026, with an ultimate completion date of January 13, 2026, was not subject to any set-aside designation, indicating the contractor competed in an unrestricted procurement environment. The award falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy that positions the company as a critical pharmaceutical supplier for Department of Defense healthcare operations.
DMS Pharmaceutical Group supplies an extensive portfolio of pharmaceutical products and medical consumables to support military healthcare facilities, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and surgical products. The PPV-G GEN V master contract, valued at $499,999,999 and effective through December 31, 2036, authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for recurring medical supply needs across the military health system. This delivery order represents one of numerous awards the contractor has received from the Defense Logistics Agency, demonstrating its sustained capability to fulfill the diverse and specialized pharmaceutical requirements of federal military medical operations.
Quick answers
Who was awarded contract SPE2DU26FEMQT?
SPE2DU26FEMQT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DU26FEMQT worth?
The government has obligated $123,589 on SPE2DU26FEMQT.
Is contract SPE2DU26FEMQT an order under another contract?
Yes. SPE2DU26FEMQT is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMQT competed?
The extent of competition for SPE2DU26FEMQT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award